)
Visual
test
Heartbeam
Heartbeam (BEAT) investor relations material
Heartbeam Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary13 Nov, 2025
Executive summary
Achieved foundational FDA 510(k) clearance for the HeartBeam System for arrhythmia assessment in December 2024, with 12-lead ECG synthesis software clearance anticipated by Q4 2025.
Entered partnerships with HeartNexus and AccurKardia for on-demand, board-certified cardiologist ECG interpretation and automated ECG analysis, supporting commercial launch.
Early access (beta) program provided valuable feedback, enhancing onboarding and user experience ahead of commercial launch.
Presented pivotal clinical study results showing 93.4% diagnostic agreement with standard 12-lead ECGs and advanced AI algorithm data at major conferences.
Expanded IP portfolio to 24 issued patents worldwide, recognized as #2 globally in 12-lead ECG innovation.
Financial highlights
Q3 2025 net loss was $5.3 million, or $0.15 per share, with operating expenses of $5.29 million and cash used in operations down 8% quarter-over-quarter.
Cash and cash equivalents at September 30, 2025, were $1.9 million, down from $2.4 million at year-end 2024.
Net cash used in operating activities for Q3 2025 was $3.2 million; for the nine months ended September 30, 2025, $11.1 million.
Raised $10.3 million from a public offering and $0.5 million from ATM sales during the nine months ended September 30, 2025.
Weighted average shares outstanding for Q3 2025: 34.4 million.
Outlook and guidance
FDA clearance for 12-lead ECG synthesis software expected by end of 2025, enabling initial commercial launch in early 2026.
Initial commercialization to focus on two U.S. regions with prominent concierge and preventive cardiology practices, with national expansion to follow.
No material commercial revenue expected in 2025; more meaningful sales and user growth anticipated in H2 2026 and into 2027.
Plans to expand indications to myocardial infarction detection, with ongoing FDA discussions and proof-of-concept studies completed.
Management plans to raise additional capital through equity, debt, or strategic partnerships.
How will initial market entry prove business model?
Post-clearance funding strategy to minimize dilution?
Pathway for myocardial infarction detection indication?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebWASH
Q4 2025 net income up 48%, adjusted EPS up 41%, AUA $7.8B, dividend yield 7.58%. - 6 FebJ
Strong growth, digital innovation, and margin expansion drive robust multi-year financial outlook. - 6 Feb004020
Operating profit rose on cost savings and high-value sales, with major US expansion underway. - 6 FebJOUT
Net sales up 31%, gross margin at 36.6%, and net loss narrowed to $3.3 million. - 6 FebPECO
Record 2025 occupancy and 7% Core FFO growth; 2026 targets 5.5% FFO growth and strong acquisitions. - 6 FebPROV
Q2 FY2026 net income rose 65% year-over-year, with higher margins and strong credit quality. - 6 FebNVDA
AI-driven digital twins and accelerated computing are set to revolutionize industrial design and manufacturing. - 6 FebCDP
2025 FFO/share rose 5.8% to $2.72, with strong leasing and investment; 2026 guidance signals more growth. - 6 FebCRI
Q1 2025 saw record revenue, a return to profit, and major new contracts in space technology. - 6 FebCRINet loss widened to 7.5m PLN in H1 2024 as revenue fell and R&D costs remained high.
Next Heartbeam earnings date
Q4 202513 Mar, 2026
Heartbeam
Next Heartbeam earnings date
Q4 202513 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
HeartBeam, Inc. is a medical technology company focused on developing innovative cardiac care solutions. The company’s primary product is a proprietary 3D-vector ECG platform designed to assist in the detection and diagnosis of heart attacks and other cardiac conditions. HeartBeam aims to provide more accurate and accessible cardiac care tools, enabling healthcare professionals to monitor and diagnose heart-related issues in both clinical and remote settings. The company serves the healthcare industry, particularly in the fields of cardiology and emergency medicine, with a focus on improving diagnostic accuracy and patient outcomes. The company is headquartered in Santa Clara, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage